1

Digital health networks as change agents of public

perceptions for clinical trials

Jessie Lee

Associate Director, Site & Patient Networks

Quintiles

2

The views and opinions expressed in the following PowerPoint slides

are those of the individual presenter and should not be attributed to

Drug Information Association, Inc. (“DIA”), its directors, officers,

employees, volunteers, members, chapters, councils, Communities or

affiliates, or any organization with which the presenter is employed or

affiliated.

These PowerPoint slides are the intellectual property of the individual

presenter and are protected under the copyright laws of the United

States of America and other countries. Used by permission. All rights

reserved. Drug Information Association, Drug Information Association

Inc., DIA and DIA logo are registered trademarks. All other trademarks

are the property of their respective owners.

Disclaimer

3

Web and mobile based platforms have made healthcare

(including clinical trial) information easily accessible for

consumers seeking answers for their medical questions in the

virtual space

Healthcare Communication & Clinical Trials

PC platform

42%

mApp platform

58%

2015 H1

Digital Health

Platform Usage

Frequency in

China

6.04bil

When searching for information

about a newly developed

condition, patients would

first research online

ONSET OF SYMPTOMS

60%30% 50%

MEDICAL CONSULT

Consults physicians F2F or e-

Consult via websites/mobile

apps

RETURNING TO SEARCH

Research diagnosis or

prescribed treatment online

65%41% 23%

SELF-MANAGED HEALTHCARE

Use mApps to manage

conditions e.g. reminders to

take medication

MONITOR & TRACK

Willingness to use

wearable devices to

manage patient health

4

By analyzing the ‘Digital Patient’ journey and digital health

networks most heavily trafficked for patient population targeted in

a clinical trial, companies can glean patient insights that are

important to consider and include in recruitment strategies or

clinical trial designs

Online conversations revealed that reliable sources of clinical trial

information is not always readily available

Insights from ‘social listening’

5

Analysis of conversations on digital health platforms help identify

gaps in information flow, barriers to enrollment and motivational

drivers etc.

Changing Public Perceptions of Clinical Trials

Patient engagement strategies can

then be designed to ensure that

the perceptions that patients &

caregivers have of clinical trials

and decisions to participate in

trials (or not) are evidence-based

and obtained from official sources

6

Jessie Lee

Associate Director, Site & Patient Networks

Quintiles

Thank You